American Oncology Network, Inc. (AONC)
OTCMKTS
· Delayed Price · Currency is USD
3.110
0.00 (0.00%)
Oct 31, 2024, 11:33 AM EDT
American Oncology Network Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Operating Revenue | 1,445 | 1,266 | 1,138 | 938.24 | 714.68 | 318.69 |
| Other Revenue | 13.32 | 13.47 | 11.74 | 5.51 | 10.07 | 1.19 |
| Revenue | 1,459 | 1,279 | 1,150 | 943.75 | 724.74 | 319.89 |
| Revenue Growth (YoY) | 19.93% | 11.27% | 21.82% | 30.22% | 126.56% | - |
| Cost of Revenue | 1,378 | 1,189 | 1,052 | 863.47 | 651.79 | 294.25 |
| Gross Profit | 80.33 | 90.31 | 98.1 | 80.28 | 72.95 | 25.64 |
| Selling, General & Admin | 120.81 | 103.43 | 89.25 | 79.37 | 50.88 | 22.03 |
| Operating Expenses | 120.81 | 103.43 | 89.25 | 79.37 | 50.88 | 22.03 |
| Operating Income | -40.48 | -13.12 | 8.84 | 0.91 | 22.07 | 3.61 |
| Interest Expense | -7.05 | -6.42 | -3.42 | -1.42 | -1.12 | -1.29 |
| Interest & Investment Income | 3.02 | 1.33 | 0.15 | 0.13 | 0.03 | 0.14 |
| Earnings From Equity Investments | -0.17 | -0.26 | - | - | - | - |
| Other Non Operating Income (Expenses) | -1.28 | -8.26 | 0.29 | 0.74 | 0.18 | 0.07 |
| EBT Excluding Unusual Items | -45.96 | -26.73 | 5.87 | 0.36 | 21.17 | 2.53 |
| Merger & Restructuring Charges | -26.97 | -31.24 | -3.28 | - | - | - |
| Other Unusual Items | 23.32 | 22.28 | -2.59 | 0.11 | - | - |
| Pretax Income | -49.61 | -35.69 | - | 0.46 | 21.17 | 2.53 |
| Income Tax Expense | 2.95 | 0.38 | - | 0.46 | -0.78 | -0.25 |
| Earnings From Continuing Operations | -52.57 | -36.07 | - | - | 21.95 | 2.77 |
| Minority Interest in Earnings | 54.39 | 30.53 | - | - | - | - |
| Net Income | 1.83 | -5.54 | - | - | 21.95 | 2.77 |
| Preferred Dividends & Other Adjustments | 6.32 | 3.58 | - | - | 2.52 | 0.11 |
| Net Income to Common | -4.49 | -9.12 | - | - | 19.43 | 2.66 |
| Net Income Growth | - | - | - | - | 691.60% | - |
| Shares Outstanding (Basic) | 11 | 7 | - | - | - | - |
| Shares Outstanding (Diluted) | 11 | 7 | - | - | - | - |
| EPS (Basic) | -0.39 | -1.36 | - | - | - | - |
| EPS (Diluted) | -2.46 | -1.36 | - | - | - | - |
| Free Cash Flow | -18.2 | -30.4 | -13.98 | -34.66 | 25.02 | -29.91 |
| Free Cash Flow Per Share | -1.59 | -4.55 | - | - | - | - |
| Gross Margin | 5.51% | 7.06% | 8.53% | 8.51% | 10.07% | 8.01% |
| Operating Margin | -2.77% | -1.03% | 0.77% | 0.10% | 3.05% | 1.13% |
| Profit Margin | -0.31% | -0.71% | - | - | 2.68% | 0.83% |
| Free Cash Flow Margin | -1.25% | -2.38% | -1.22% | -3.67% | 3.45% | -9.35% |
| EBITDA | -31.45 | -4.67 | 15.56 | 6.99 | 25.73 | 4.62 |
| EBITDA Margin | -2.16% | -0.36% | 1.35% | 0.74% | 3.55% | 1.44% |
| D&A For EBITDA | 9.03 | 8.45 | 6.72 | 6.08 | 3.66 | 1.01 |
| EBIT | -40.48 | -13.12 | 8.84 | 0.91 | 22.07 | 3.61 |
| EBIT Margin | -2.77% | -1.03% | 0.77% | 0.10% | 3.05% | 1.13% |
| Effective Tax Rate | - | - | - | 100.00% | - | - |
| Revenue as Reported | 1,459 | 1,279 | 1,150 | 943.75 | 724.74 | 319.89 |
Source: S&P Capital IQ. Standard template. Financial Sources.